STOCK TITAN

Enhabit Inc - EHAB STOCK NEWS

Welcome to our dedicated news page for Enhabit (Ticker: EHAB), a resource for investors and traders seeking the latest updates and insights on Enhabit.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Enhabit's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Enhabit's position in the market.

Rhea-AI Summary
Enhabit, Inc. (EHAB) will report its Q1 2024 results on May 8, 2024, and host a webcast and conference call on May 9, 2024. Details for participation are provided.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.74%
Tags
-
Rhea-AI Summary
Enhabit, Inc. (EHAB) receives 2024 Top Workplaces USA award from Energage, reinforcing its position as a leading home health and hospice provider.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.96%
Tags
none
-
Rhea-AI Summary
Enhabit, Inc. (EHAB) announces positive fourth-quarter results and upcoming conference call. President and CEO Barb Jacobsmeyer highlights payor innovation and strong performance.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
22.14%
Tags
Rhea-AI Summary
Enhabit, Inc. (EHAB) will report Q4 2023 results on March 6, 2024, and host a webcast and conference call on March 7, 2024. The conference call details are provided for participation. The webcast link and online replay will be available on Enhabit's investor website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.34%
Tags
-
Rhea-AI Summary
EHAB: Enhabit, Inc. Revises Full-Year Guidance, Reports Q3 '23 Results, and Highlights Continued Growth in Home Health Medicare Advantage Admissions
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.02%
Tags
-
Rhea-AI Summary
Enhabit, Inc. provides updates on Q3 results and strategic review process.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.12%
Tags
Rhea-AI Summary
Enhabit, Inc. has initiated a review of strategic alternatives, including a potential sale or merger. The company aims to enhance value for stockholders and ensure exceptional care for patients.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.95%
Tags
none
-
Rhea-AI Summary
Enhabit, Inc. (NYSE: EHAB) reported its Q2 2023 results, including net service revenue of $262.3 million, a net loss of $74.1 million, and adjusted EBITDA of $23.9 million. The company negotiated ten new contracts with Medicare Advantage payors and increased clinical staff with 203 net new full-time nursing hires. However, the pace of progress has not met initial guidance. The company also announced its intent to launch a strategic alternatives process, subject to conditions in the Tax Matters Agreement.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-13.8%
Tags
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.19%
Tags
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.43%
Tags
none
Enhabit Inc

NYSE:EHAB

EHAB Rankings

EHAB Stock Data

521.62M
43.99M
2.3%
117.42%
7.04%
Dental Laboratories
Manufacturing
Link
United States
Dallas